199 related articles for article (PubMed ID: 8388496)
21. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
[TBL] [Abstract][Full Text] [Related]
22. Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody.
Brousset P; Butet V; Chittal S; Selves J; Delsol G
Lab Invest; 1992 Oct; 67(4):457-64. PubMed ID: 1331609
[TBL] [Abstract][Full Text] [Related]
23. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
Kerr BM; Lear AL; Rowe M; Croom-Carter D; Young LS; Rookes SM; Gallimore PH; Rickinson AB
Virology; 1992 Mar; 187(1):189-201. PubMed ID: 1310556
[TBL] [Abstract][Full Text] [Related]
24. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
Hu LF; Minarovits J; Cao SL; Contreras-Salazar B; Rymo L; Falk K; Klein G; Ernberg I
J Virol; 1991 Mar; 65(3):1558-67. PubMed ID: 1847471
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome.
Pfitzner AJ; Tsai EC; Strominger JL; Speck SH
J Virol; 1987 Sep; 61(9):2902-9. PubMed ID: 3039177
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma].
Han AJ; Zong YS; Zhang M; Cao SM; Lin SX; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):534-8. PubMed ID: 14761599
[TBL] [Abstract][Full Text] [Related]
27. EBV gene expression in an NPC-related tumour.
Hitt MM; Allday MJ; Hara T; Karran L; Jones MD; Busson P; Tursz T; Ernberg I; Griffin BE
EMBO J; 1989 Sep; 8(9):2639-51. PubMed ID: 2479554
[TBL] [Abstract][Full Text] [Related]
28. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
Schaefer BC; Strominger JL; Speck SH
J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
Tierney RJ; Steven N; Young LS; Rickinson AB
J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
[TBL] [Abstract][Full Text] [Related]
30. Rearranged Epstein-Barr virus genomes and clonal origin in nasopharyngeal carcinoma.
Shimakage M; Chatani M; Ikegami N; Hirai K
Jpn J Cancer Res; 1989 Jul; 80(7):612-6. PubMed ID: 2551868
[TBL] [Abstract][Full Text] [Related]
31. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
33. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
[TBL] [Abstract][Full Text] [Related]
34. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
35. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
[TBL] [Abstract][Full Text] [Related]
36. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
Rowe M; Lear AL; Croom-Carter D; Davies AH; Rickinson AB
J Virol; 1992 Jan; 66(1):122-31. PubMed ID: 1309242
[TBL] [Abstract][Full Text] [Related]
37. Gene mapping of an Epstein-Barr virus isolate obtained from a nasopharyngeal carcinoma.
Zhang HY; Dangel A; Takimoto T; Glaser R
Intervirology; 1989; 30(1):52-60. PubMed ID: 2542179
[TBL] [Abstract][Full Text] [Related]
38. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
39. Expression of the complementary-strand transcripts from BamHI-A region of the Epstein-Barr virus genome in various induced virus-carrying B cell lines.
Zhang CX; Ooka T
Virology; 1995 Apr; 208(1):180-8. PubMed ID: 11831698
[TBL] [Abstract][Full Text] [Related]
40. Identification of a promoter for the latent membrane protein 1 gene of Epstein-Barr virus that is specifically activated in human epithelial cells.
Chang MH; Ng CK; Lin YJ; Liang CL; Chung PJ; ChenML ; Tyan YS; Hsu CY; Shu CH; Chang YS
DNA Cell Biol; 1997 Jul; 16(7):829-37. PubMed ID: 9260926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
